News
OPHLF
16.54
NaN%
--
Bladder Cancer Trial Completion Puts Opdivo in Focus for BMY and Ono Investors
TipRanks · 3d ago
Ono Pharma’s New Cancer Trial Adds Early-Stage Upside—and Risk—for OPHLF Investors
TipRanks · 08/26 16:30
ONO Pharmaceutical Co (OPHLF) Gets a Sell from Goldman Sachs
TipRanks · 08/17 11:40
ONO-6414: New First-in-Human Ulcerative Colitis Study Puts ONO Pharmaceutical on Investors’ Radar
TipRanks · 08/06 16:41
ONO Pharmaceutical Q1: Record Sales, Margin Strain
TipRanks · 08/02 00:07
Ono Pharmaceutical GAAP EPS of ¥ 51.38, revenue of ¥ 116.1B
Seeking Alpha · 07/31 13:27
Ono Pharmaceutical Lifts Q1 Profits Despite Revenue Decline, Confirms FY2026 Outlook
TipRanks · 07/31 03:22
Ono Pharma Halts Early Lymphoma Trial, Raising Fresh Questions for Investors
TipRanks · 07/29 16:30
Ono’s New GIST Study Puts Early‑Stage Oncology Back in Focus for OPHLF Investors
TipRanks · 07/20 16:31
Ono Pharma’s ONO-1110 Pain Trial Reaches Completion, Setting Up a Key Readout
TipRanks · 07/15 16:30
ONO-1110 Depression Trial Completion: What It Means for OPHLF Investors
TipRanks · 07/08 16:30
ONO’s ONO‑1110 Trial Completion Puts Social Anxiety Bet in Investor Focus
TipRanks · 07/08 16:30
ONO’s Tirabrutinib Liver Study Completion: What It Means for OPHLF Investors
TipRanks · 06/26 16:31
Real-World Data on Nivolumab Plus Chemo in Japanese Gastric Cancer: What Investors Should Watch
TipRanks · 06/18 16:31
Ono’s ONO-4578 Breast Cancer Combo Clears Phase I Milestone, Setting Up the Next Investor Catalyst
TipRanks · 06/05 16:31
Analysts Are Neutral on These Healthcare Stocks: CSL (CMXHF), ONO Pharmaceutical Co (OPHLF)
TipRanks · 05/31 12:20
ONO’s ONO-7018 Trial Termination: What It Means for OPHLF Investors
TipRanks · 05/29 16:31
Ono’s Real-World Tirabrutinib Study in Taiwan Reaches Completion, Setting Up a New Catalyst for OPHLF
TipRanks · 05/20 16:30
Ono’s Phase 3 Sapablursen Trial Targets Polycythemia Vera Upside for OPHLF Investors
TipRanks · 05/08 16:34
Ono Pharmaceutical reports FY results
Seeking Alpha · 05/08 09:55
More
Webull provides a variety of real-time OPHLF stock news. You can receive the latest news about Ono Pharmaceutic through multiple platforms. This information may help you make smarter investment decisions.
About OPHLF
Ono Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the pharmaceutical business. The Company is engaged in the manufacture and sale of prescription and over-the-counter drugs. The Company has been particularly focused on research and development of prescription drugs, positioning them as its core business. The Company’s products include injectables, oral medications, and patches.